ABI-009 (Nab-rapamycin) for Surgically-Refractory Epilepsy (RaSuRE)

Clinical trial NCT03646240 · COMPLETED

Trial details

NCT number: NCT03646240
Sponsor: Seattle Children's Hospital
Status: COMPLETED
Phase: Phase 1
Study type: INTERVENTIONAL

Epilepsy Intractable

Start date: 2018-07-31
Primary completion: 2022-08-22
Enrollment: 14

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.